We bring you data and information on the most pressing medical freedom topics to defend and protect children.
At Canta, we are dedicated to an impact investment model and data analysis. We publish news and data to support medical freedom causes including vaccine safety, right to life, and medical decision making rights. We are making impact investments and taking action based on data, published peer-reviewed literature, and what a courageous minority of liberty-minded and health conscious Americans are bringing to light to protect their children, and their children’s children.
If you value medical freedom, liberty, and safety for children, you’ve come to the right place.
In God we trust, all others bring data.
Investing in Integrative Medecine
Integrative Medicine (IM) is healing-oriented medicine that takes account of the whole person. It emphasizes the therapeutic relationship between practitioner and patient, is informed by evidence, and makes use of all appropriate therapies.
At Canta, we deploy an impact investment strategy into the integrative healthcare industry. Our investment strategy entails both a healing oriented approach and the improvement of quality of life in palliative care. Our impact investments are currently focused on evidence based research, neural-inflammatory response and cardiovascular and neuromodulation treatments and therapies. We are actively investing time, talent and treasure. To learn more or give us a pitch, contact us.
Ending Childhood Genetic Diseases
Rare childhood genetic diseases are not rare. Over 400 million people are affected by 7,000 rare disease globally. The majority of these conditions are not well understood, and less than 5% have approved treatments.
Canta is part of the global rare disease community of parents, researchers and professionals. Worldwide, patients and families are banning together to meet challenges to end childhood genetic diseases. Our focus at Canta is supporting causes helping a group of neurodegenerative genetic diseases called Leukodystrophies.
The 50+ leukodystrophies make up a group of rare genetic disorders that affect the central nervous system by disrupting the growth or maintenance of the myelin sheath, which insulates nerve cells. These disorders are progressive, meaning that they tend to worsen throughout the life of the patient.